Active Clinical Research for Skin Cancers
Comprehensive Cancer Centers is currently running this clinical research study for skin cancer:
A Phase 3 Study of Fixed Dose Combinations of Fianlimab and Cemiplimab Versus Relatlimab and Nivolumab in Participants with Unresectable or Metastatic Melanoma
Study#: i3247
Contact Us: For information about this clinical study, Email Us.